The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?

Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose.

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...

The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new vaccines will be available.

The Pfizer vaccine is the first to receive FDA approval, while the Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. For children ages 12 to 15, Pfizer's ...

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.

A syringe is prepared with the Pfizer COVID-19 vaccine at a vaccination clinic in Chester, Pa., on Dec. 15, 2021. Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is ...

Pfizer's early data has spotlighted the future of COVID-19 vaccine distribution, particularly because the company's vaccine presents a potential hurdle: It needs to be stored at around -70 degrees ...

Pfizer is the first of several companies to report results from ongoing late-stage trials. Moderna, another company in the race for a vaccine, launched a trial on July 27 -- the same day as Pfizer.